TCT-449 Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent versus Cobalt-Chromium Everolimus-Eluting Stent in De Novo Native Coronary Lesions: The Final 5-Year Results of the TARGET I Randomized Controlled Trial

Bo Xu; Changdong Guan; Yuejin Yang; Yaling Han; Shao-Liang Chen; Alexandra Lansky; Martin Leon; Runlin Gao

doi:10.1016/j.jacc.2016.09.585

TCT-449 Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent versus Cobalt-Chromium Everolimus-Eluting Stent in De Novo Native Coronary Lesions: The Final 5-Year Results of the TARGET I Randomized Controlled Trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2016.09.585 ◽

2016 ◽

Vol 68 (18) ◽

pp. B181

Author(s):

Bo Xu ◽

Changdong Guan ◽

Yuejin Yang ◽

Yaling Han ◽

Shao-Liang Chen ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Biodegradable Polymer ◽

De Novo ◽

Controlled Trial ◽

Cobalt Chromium ◽

Randomized Controlled ◽

Coronary Lesions ◽

Sirolimus Eluting Stent

Download Full-text

TCT-567 Long-Term Outcomes With an Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent Versus a Cobalt-Chromium Everolimus-Eluting Stent in Single De Novo Coronary Lesions: Four-Year Results of the TARGET I Randomized Controlled Trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2015.08.1037 ◽

2015 ◽

Vol 66 (15) ◽

pp. B229-B230

Author(s):

Bo Xu ◽

Changdong Guan ◽

Yuejin Yang ◽

Ma Changsheng ◽

Yaling Han ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Biodegradable Polymer ◽

De Novo ◽

Controlled Trial ◽

Cobalt Chromium ◽

Long Term Outcomes ◽

Randomized Controlled ◽

Coronary Lesions ◽

Sirolimus Eluting Stent

Download Full-text

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial

Trials ◽

10.1186/1745-6215-13-55 ◽

2012 ◽

Vol 13 (1) ◽

Cited By ~ 4

Author(s):

Francesco Burzotta ◽

Marta Francesca Brancati ◽

Carlo Trani ◽

Italo Porto ◽

Antonella Tommasino ◽

...

Keyword(s):

Randomized Controlled Trial ◽

De Novo ◽

Controlled Trial ◽

Bare Metal Stent ◽

Bare Metal ◽

Metal Stent ◽

Randomized Controlled ◽

Drug Eluting ◽

Coronary Lesions ◽

Drug Eluting Balloon

Download Full-text

Efficacy and safety of a biodegradable polymer sirolimus-eluting stent in primary percutaneous coronary intervention: a randomized controlled trial

Archives of Medical Science ◽

10.5114/aoms.2013.39793 ◽

2013 ◽

Vol 6 ◽

pp. 1040-1048 ◽

Cited By ~ 2

Author(s):

Qiang Li ◽

Zichuan Tong ◽

Lefeng Wang ◽

Jianjun Zhang ◽

Yonggui Ge ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Percutaneous Coronary Intervention ◽

Primary Percutaneous Coronary Intervention ◽

Biodegradable Polymer ◽

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Sirolimus Eluting Stent

Download Full-text

Reply to Comments on “Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis - A randomized controlled trial”

Journal of Hepatology ◽

10.1016/j.jhep.2021.06.005 ◽

2021 ◽

Author(s):

Bettina Geidl-Flueck ◽

Philipp A. Gerber

Keyword(s):

Randomized Controlled Trial ◽

De Novo ◽

Controlled Trial ◽

De Novo Lipogenesis ◽

Randomized Controlled ◽

Sweetened Beverages

Download Full-text

TCT-592 Lower Five Year Event Rates In The Genous Endothelial Progenitor Cell Capturing Stent Compared With A Drug Eluting Stent In De-novo Coronary Artery Lesions With A High-risk Of Restenosis; A Randomized Controlled Trial

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.07.656 ◽

2014 ◽

Vol 64 (11) ◽

pp. B172-B173

Author(s):

Pier Woudstra ◽

Marcel A. Beijk ◽

Karel T. Koch ◽

Jan Baan ◽

Marije M. Vis ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Coronary Artery ◽

Progenitor Cell ◽

De Novo ◽

Controlled Trial ◽

Drug Eluting Stent ◽

Coronary Artery Lesions ◽

Randomized Controlled ◽

Drug Eluting ◽

Event Rates

Download Full-text

Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions　― Subanalysis of a Randomized Controlled Trial ―

Circulation Journal ◽

10.1253/circj.cj-17-1000 ◽

2018 ◽

Vol 82 (7) ◽

pp. 1788-1796 ◽

Cited By ~ 2

Author(s):

Kentaro Ejiri ◽

Toru Miyoshi ◽

Kunihisa Kohno ◽

Makoto Nakahama ◽

Masayuki Doi ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Percutaneous Coronary Intervention ◽

Protective Effect ◽

Ischemic Preconditioning ◽

Controlled Trial ◽

Myocardial Damage ◽

Coronary Intervention ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Coronary Lesions

Download Full-text

Early Calcineurin Inhibitors Elimination Improves Renal Function in De Novo Heart Transplant Recipients: The Results of a Randomized Controlled Trial (SCHEDULE Trial).

Transplantation Journal ◽

10.1097/00007890-201407151-00005 ◽

2014 ◽

Vol 98 ◽

pp. 3 ◽

Cited By ~ 1

Author(s):

V. Sigurdardottir ◽

A. Andreassen ◽

F. Gustafsson ◽

H. Eiskjaer ◽

G. Radegran ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Renal Function ◽

Heart Transplant ◽

De Novo ◽

Controlled Trial ◽

Calcineurin Inhibitors ◽

Transplant Recipients ◽

Randomized Controlled ◽

Heart Transplant Recipients

Download Full-text

The angiography-guided spot versus entire stenting in patients with long coronary lesions trial: Study design and rationale for a randomized controlled trial protocol

Contemporary Clinical Trials Communications ◽

10.1016/j.conctc.2020.100523 ◽

2020 ◽

Vol 17 ◽

pp. 100523

Author(s):

Ju Yeol Baek ◽

Seung Woon Rha ◽

Byoung Geol Choi ◽

Cheol Ung Choi ◽

Kyoung-Ha Park ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Study Design ◽

Controlled Trial ◽

Trial Protocol ◽

Randomized Controlled ◽

Coronary Lesions

Download Full-text

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

American Journal of Transplantation ◽

10.1111/j.1600-6143.2006.01552.x ◽

2006 ◽

Vol 6 (12) ◽

pp. 2912-2921 ◽

Cited By ~ 101

Author(s):

M. Salvadori ◽

K. Budde ◽

B. Charpentier ◽

J. Klempnauer ◽

B. Nashan ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Renal Transplantation ◽

De Novo ◽

Controlled Trial ◽

Randomized Controlled

Download Full-text

Everolimus and Cyclosporine Equally Improve QoL in De Novo Heart Transplanted Patients: The Results of a Randomized Controlled Trial (SCHEDULE Trial)

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2014.01.343 ◽

2014 ◽

Vol 33 (4) ◽

pp. S128

Author(s):

A. Relbo ◽

I. Grov ◽

B. Andersson ◽

F. Gustafsson ◽

H. Eiskjær ◽

...

Keyword(s):

Randomized Controlled Trial ◽

De Novo ◽

Controlled Trial ◽

Randomized Controlled

Download Full-text

TCT-449 Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent versus Cobalt-Chromium Everolimus-Eluting Stent in De Novo Native Coronary Lesions: The Final 5-Year Results of the TARGET I Randomized Controlled Trial

TCT-567 Long-Term Outcomes With an Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent Versus a Cobalt-Chromium Everolimus-Eluting Stent in Single De Novo Coronary Lesions: Four-Year Results of the TARGET I Randomized Controlled Trial

INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial

Efficacy and safety of a biodegradable polymer sirolimus-eluting stent in primary percutaneous coronary intervention: a randomized controlled trial

Reply to Comments on “Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis - A randomized controlled trial”

TCT-592 Lower Five Year Event Rates In The Genous Endothelial Progenitor Cell Capturing Stent Compared With A Drug Eluting Stent In De-novo Coronary Artery Lesions With A High-risk Of Restenosis; A Randomized Controlled Trial

Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions ― Subanalysis of a Randomized Controlled Trial ―

Early Calcineurin Inhibitors Elimination Improves Renal Function in De Novo Heart Transplant Recipients: The Results of a Randomized Controlled Trial (SCHEDULE Trial).

The angiography-guided spot versus entire stenting in patients with long coronary lesions trial: Study design and rationale for a randomized controlled trial protocol

FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia

Everolimus and Cyclosporine Equally Improve QoL in De Novo Heart Transplanted Patients: The Results of a Randomized Controlled Trial (SCHEDULE Trial)

Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions　― Subanalysis of a Randomized Controlled Trial ―